Current indications and limits of pancreatic islet transplantation in diabetic nephropathy

Michele Masetti, Luca A Inverardi, Alessandra Ranuncoli, Giuseppe Iaria, Francesco Lupo, Caterina Vizzardelli, Norma S Kenyon, Rodolfo Alejandro, Camillo Ricordi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Insulin-dependent diabetes mellitus (IDDM) is a disease caused by a progressive autoimmune destruction of the insulin-producing β-cells within the pancreas. A major task of diabetes research consists in developing new forms of treatment to delay or prevent the development of the chronic complications associated with the disease. Islet transplantation could become an attractive alternative to whole organ transplantation, since it is a simpler and safer procedure. However, the requirement for long-term immunosuppression has limited the indication of islet transplantation to patients receiving a simultaneous kidney transplant or already bearing one. While the majority of recipients of islet allografts did not become insulin independent, the field has witnessed significant progress and the long-term results in patients with even partial graft function are comparable or better than those achievable with intensive insulin therapy. Recent trials of donor bone marrow infusions combined with solid organ transplants are in progress to determine whether donor-specific tolerance can be achieved with the potential to expand the future indications of islet transplantation in diabetes.

Original languageEnglish
Pages (from-to)245-252
Number of pages8
JournalJournal of Nephrology
Volume10
Issue number5
StatePublished - Sep 1 1997

Fingerprint

Islets of Langerhans Transplantation
Diabetic Nephropathies
Insulin
Transplants
Tissue Donors
Organ Transplantation
Type 1 Diabetes Mellitus
Immunosuppression
Allografts
Pancreas
Bone Marrow
Kidney
Therapeutics
Research

Keywords

  • C-peptide
  • Diabetes Mellitus
  • Graft rejection
  • Graft survival
  • Immune tolerance
  • Immunosuppression
  • Insulin
  • Islets of Langerhans
  • Islets of Langerhans transplantation
  • Pancreas transplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Masetti, M., Inverardi, L. A., Ranuncoli, A., Iaria, G., Lupo, F., Vizzardelli, C., ... Ricordi, C. (1997). Current indications and limits of pancreatic islet transplantation in diabetic nephropathy. Journal of Nephrology, 10(5), 245-252.

Current indications and limits of pancreatic islet transplantation in diabetic nephropathy. / Masetti, Michele; Inverardi, Luca A; Ranuncoli, Alessandra; Iaria, Giuseppe; Lupo, Francesco; Vizzardelli, Caterina; Kenyon, Norma S; Alejandro, Rodolfo; Ricordi, Camillo.

In: Journal of Nephrology, Vol. 10, No. 5, 01.09.1997, p. 245-252.

Research output: Contribution to journalArticle

Masetti, M, Inverardi, LA, Ranuncoli, A, Iaria, G, Lupo, F, Vizzardelli, C, Kenyon, NS, Alejandro, R & Ricordi, C 1997, 'Current indications and limits of pancreatic islet transplantation in diabetic nephropathy', Journal of Nephrology, vol. 10, no. 5, pp. 245-252.
Masetti M, Inverardi LA, Ranuncoli A, Iaria G, Lupo F, Vizzardelli C et al. Current indications and limits of pancreatic islet transplantation in diabetic nephropathy. Journal of Nephrology. 1997 Sep 1;10(5):245-252.
Masetti, Michele ; Inverardi, Luca A ; Ranuncoli, Alessandra ; Iaria, Giuseppe ; Lupo, Francesco ; Vizzardelli, Caterina ; Kenyon, Norma S ; Alejandro, Rodolfo ; Ricordi, Camillo. / Current indications and limits of pancreatic islet transplantation in diabetic nephropathy. In: Journal of Nephrology. 1997 ; Vol. 10, No. 5. pp. 245-252.
@article{2315b46e65bd43e5a10feedb869cc6dd,
title = "Current indications and limits of pancreatic islet transplantation in diabetic nephropathy",
abstract = "Insulin-dependent diabetes mellitus (IDDM) is a disease caused by a progressive autoimmune destruction of the insulin-producing β-cells within the pancreas. A major task of diabetes research consists in developing new forms of treatment to delay or prevent the development of the chronic complications associated with the disease. Islet transplantation could become an attractive alternative to whole organ transplantation, since it is a simpler and safer procedure. However, the requirement for long-term immunosuppression has limited the indication of islet transplantation to patients receiving a simultaneous kidney transplant or already bearing one. While the majority of recipients of islet allografts did not become insulin independent, the field has witnessed significant progress and the long-term results in patients with even partial graft function are comparable or better than those achievable with intensive insulin therapy. Recent trials of donor bone marrow infusions combined with solid organ transplants are in progress to determine whether donor-specific tolerance can be achieved with the potential to expand the future indications of islet transplantation in diabetes.",
keywords = "C-peptide, Diabetes Mellitus, Graft rejection, Graft survival, Immune tolerance, Immunosuppression, Insulin, Islets of Langerhans, Islets of Langerhans transplantation, Pancreas transplantation",
author = "Michele Masetti and Inverardi, {Luca A} and Alessandra Ranuncoli and Giuseppe Iaria and Francesco Lupo and Caterina Vizzardelli and Kenyon, {Norma S} and Rodolfo Alejandro and Camillo Ricordi",
year = "1997",
month = "9",
day = "1",
language = "English",
volume = "10",
pages = "245--252",
journal = "Journal of Nephrology",
issn = "1121-8428",
publisher = "Wichtig Publishing",
number = "5",

}

TY - JOUR

T1 - Current indications and limits of pancreatic islet transplantation in diabetic nephropathy

AU - Masetti, Michele

AU - Inverardi, Luca A

AU - Ranuncoli, Alessandra

AU - Iaria, Giuseppe

AU - Lupo, Francesco

AU - Vizzardelli, Caterina

AU - Kenyon, Norma S

AU - Alejandro, Rodolfo

AU - Ricordi, Camillo

PY - 1997/9/1

Y1 - 1997/9/1

N2 - Insulin-dependent diabetes mellitus (IDDM) is a disease caused by a progressive autoimmune destruction of the insulin-producing β-cells within the pancreas. A major task of diabetes research consists in developing new forms of treatment to delay or prevent the development of the chronic complications associated with the disease. Islet transplantation could become an attractive alternative to whole organ transplantation, since it is a simpler and safer procedure. However, the requirement for long-term immunosuppression has limited the indication of islet transplantation to patients receiving a simultaneous kidney transplant or already bearing one. While the majority of recipients of islet allografts did not become insulin independent, the field has witnessed significant progress and the long-term results in patients with even partial graft function are comparable or better than those achievable with intensive insulin therapy. Recent trials of donor bone marrow infusions combined with solid organ transplants are in progress to determine whether donor-specific tolerance can be achieved with the potential to expand the future indications of islet transplantation in diabetes.

AB - Insulin-dependent diabetes mellitus (IDDM) is a disease caused by a progressive autoimmune destruction of the insulin-producing β-cells within the pancreas. A major task of diabetes research consists in developing new forms of treatment to delay or prevent the development of the chronic complications associated with the disease. Islet transplantation could become an attractive alternative to whole organ transplantation, since it is a simpler and safer procedure. However, the requirement for long-term immunosuppression has limited the indication of islet transplantation to patients receiving a simultaneous kidney transplant or already bearing one. While the majority of recipients of islet allografts did not become insulin independent, the field has witnessed significant progress and the long-term results in patients with even partial graft function are comparable or better than those achievable with intensive insulin therapy. Recent trials of donor bone marrow infusions combined with solid organ transplants are in progress to determine whether donor-specific tolerance can be achieved with the potential to expand the future indications of islet transplantation in diabetes.

KW - C-peptide

KW - Diabetes Mellitus

KW - Graft rejection

KW - Graft survival

KW - Immune tolerance

KW - Immunosuppression

KW - Insulin

KW - Islets of Langerhans

KW - Islets of Langerhans transplantation

KW - Pancreas transplantation

UR - http://www.scopus.com/inward/record.url?scp=0030718542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030718542&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 245

EP - 252

JO - Journal of Nephrology

JF - Journal of Nephrology

SN - 1121-8428

IS - 5

ER -